GeoVax Awarded NIH Grant for Novel Zika Vaccine
by Press Release from Outbreak News Today on (#3R16D)
Biotechnology company, GeoVax Labs, Inc announced this week that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant in support of its novel Zika vaccine development program. The grant award of $300,000 will fund the second year of ["]
The post GeoVax Awarded NIH Grant for Novel Zika Vaccine appeared first on Outbreak News Today.